Northern Trust’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZNTL
SFCM
Northern Trust's ZNTL Position: Q3 2026 in Review
Northern Trust increased its Zentalis Pharmaceuticals (ZNTL) stake by 3.9% in Q3 2026, buying an estimated $61.3K and bringing the position to 403,490 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3367.
Northern Trust first reported a position in ZNTL in Q2 2020 and has held it in 26 quarters since. The position peaked at $29.4M in Q4 2021. 127 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.
- Northern Trust held 403,490 shares of Zentalis Pharmaceuticals worth $1.12M as of Q3 2026.
- Northern Trust bought 15,191 Zentalis Pharmaceuticals shares in Q3 2026, an estimated $61.3K.
- Zentalis Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #3367 holding.
- Northern Trust first reported a position in Zentalis Pharmaceuticals in Q2 2020 and has held it in 26 quarters since.
- Northern Trust's Zentalis Pharmaceuticals position peaked at $29.4M in Q4 2021.
- 127 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.